Assessment of DNA damage in peripheral blood lymphocytes from patients with benign and malignant thyroid disorders

Hacettepe University Journal of the Faculty of Pharmacy

Volumn 28, Issue 1, 2008, Pages 1-14

  Ündeǧer, Ülkü ^a   Şahin, Tevfik Tolga ^b   Yüksel, Osman ^b   Bostanci, Hasan ^b   Kurukahvecioǧlu, Osman ^b   Taneri, Ferit ^b   Başaran, Nurşen ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

Comet assay; DNA damage; Single cell gel electrophoresis; Thyroid cancer; Thyroid tumours

Indexed keywords

ADULT; ARTICLE; ASPIRATION BIOPSY; BLOOD SAMPLING; CANCER RISK; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PERIPHERAL LYMPHOCYTE; PREOPERATIVE EVALUATION; SMOKING HABIT; THYROID CANCER; THYROID PAPILLARY CARCINOMA; THYROID TUMOR; THYROIDECTOMY; THYROIDITIS; TOXIC GOITER;

EID: 77953374522     PISSN: 13000608     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Bartek, J., Lukas, C., Lukas, J.: Checking on DNA damage in S phase. Nature Reviews in Mol. Cell Biol., 5, 792-804 (2004)
2. Kastan, M., Bartek, J.: Cell cycle checkpoints and cancer. Nature, 432, 316-323 (2004)
3. Bartek, J., Lukas, J.: Pathways governing G1/S transition and their response to DNA damage. FEBS Lett., 490, 117-122 (2001)
4. Bartek, J., Lukas, J.: The Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell, 3, 421-429 (2003)
5. Lukas, J., Lukas, C., Bartek, J.: Mammalian cell cycle checkpoints: signaling pathways and their organization in space and time. DNA Repair, 3; 997-1007 (2004)
6. Hiroshimaya, T., Takahashi, H., Yao, K., Inagi, K., Nakayama, M., Makoshi, T., Nagai, H., Okamoto, M.: Clinical review of thyroid malignant tumour. Acta Otolaryngol., 547, 85-87 (2002)
7. Ito, Y., Hirokawa, M., Jikuzono, T., Takamura, Y., Miya, A., Kobayashi, K., Matsuzuka, F., Kuma, K., Miyauchi, A.: Extranodal Tumour Extension to Adjacent Organs Predicts a Worse Cause-specific Survival in Patients with Papillary Thyroid Carcinoma. World J. Surg., 31, 1194-1201 (2007)
8. Rigual, N.R., Anderson, G.R., Loree, T.R., Wiseman, S., Alrawi, S., Stoler, D.L.: Molecular prognosticators and genomic instability in papillary thyroid cancer. Laryngoscope, 115, 1479-1485 (2005)
9. Calderon-Garciduenas, L., Osnaya, N., Rodriguez-Alcaraz, A., Villareal-Calderon, A.: DNA damage in nasal respiratory epithelium from children exposed to urban pollution. Environ. Mol. Mutagen., 30, 11-20 (1997)
10. Andreoli, C., Leopardi, P., Crebelli, R.: Detection of DNA damage in human lymphocytes by alkaline single cell gel electrophoresis after exposure to benzene or benzene metabolites. Mutat. Res., 377, 95-104 (1997)
11. Vodicka, P., Tvordik, T., Osterman-Golkar, S.: An evaluation of styrene genotoxicity using several biomarkers in a 3-year follow-up study of hand-lamination workers. Mutat. Res., 445, 205-224 (1999)
12. Zhu, C.Q., Lam, T.H., Jiang, C.Q., Wei, B.X., Lou, X., Liu, W.W., Lao, X.Q., Chen, Y.H.: Lymphocyte DNA damage in cigarette factory workers measured by the Comet Assay. Mutat. Res., 444, 1-6 (1999)
13. Moller, P., Knudsen, L.E., Loft, S., Wallin, H.: The comet assay as a rapid test in biomonitoring occupational exposure to DNA-damaging agents and effect of confounding factors. Cancer Epidem. Biomar. Prev., 9, 1005-1015 (2000)
14. Boyum, A.: Isolation of lymphocytes, granulocytes, and macrophages. Scand. J. Immunol., 5, 9-15, (1976)
15. Singh, N.P., McCoy, M.T., Tice, R.R., Schneider, E.L.: A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res., 175, 184-191 (1988)
16. Collins, A.R., Dusinska, M., Franklin, M., Somorovska, M., Petrovska, H., Fillion, L., Panayiotidis, Ö., Raslova, K., Vaughan, N.: Comet assay in human biomonitoring studies: reliability, validation and applications. Environ. Mol. Mutagen., 30, 139-146 (1997)
17. Trimboli, P., Ulisse, S., Graziano, F.M., Marzullo, A., Ruggieri, M., Calvanese, A., Piccirilli, F., Cavaliere, R., Fumarola, A., DaArmiento, M.: Trend in Thyroid Carcinoma Size, Age at Diagnosis, and Histology in a Retrospective Study of 500 Cases Diagnosed Over 20 Years. Thyroid, 16; 1151-1155 (2006)
18. Molecular basis of thyroid cancer. NR Farid editor. Amsterdam: Kluwer Academic Publishers, (2004)
19. Hayat, M.J., Howlader, N., Reichman, M.E., Edwards, B.K.: Cancer statistics, trends and multiple primary cancer analyses from the surveillance, epidemiology, and end results (SEER) program. The Oncologist, 12, 20-37 (2007)
20. Ellsworth, D.L., Ellsworth, R.E., Liebman, M.N., Hooke, J.A., Shriver, C.D.: Genomic instability in histologically normal breast tissues: implications for carcinogenesis. Lancet Oncol., 5, 753-758 (2004)
21. Zheng, Y.L., Loffredo, C.A., Yu, Z., Jones, R.T., Krasna, M.J., Alberg, A.J., Yung, R., Perlmutter, D., Enewold, L., Harris, C.C., Shields, P.G.: Bleomycin-induced chromosome breaks as a risk marker for lung cancer: a case-control study with population and hospital controls. Carcinogenesis, 24, 269-274 (2003)
22. Venkitaraman, A.R.: Preface: Chromosomal instability and breast cancer pathogenesis. J. Mammary Gland Biol. & Neoplasia, 9, 217-220 (2004)
23. Sigurdson, A.J., Hauptmann, M., Alexander, B.H., Doody, M.M., Thomas, C.B., Struewig, J.P., Jones, I.M.: DNA damage among thyroidcancer and multiple cancer cases, controls, and long-lived individuals. Mutat. Res., 586, 173-188 (2005)
24. Smith, T.R., Miller, M.S., Lohman, K.K., Case, L.D., Hu, J.J.: DNA damage and breast cancer risk. Carcinogenesis, 24, 883-889 (2003)
25. Schabath, M.B., Spitz, M.R., Grossmann, H.B., Zhang, K., Dinney, C.P., Zheng, D.J., Wu, X.: Genetic instability in bladder cancer assessed by the comet assay. J. Natl. Cancer Inst., 95, 540-547 (2003)
26. Georgoulis, V.G., Vassiliou, L.V., Karakaidos, P., Zacharias, P., Kotsiras, A., Likoǧlu, T.: Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature, 434, 907-913 (2005)
27. Mohrenweiser, H.W., Jones, I.M.: Variation in DNA repair is a factor in cancer susceptibility: a paradigm for the promises and perils of individual and population risk estimation? Mutat. Res., 400, 15-24 (1998)
28. Schmezer, P., Rajaee-Behbahani, N., Risch, A., Thiel, S., Rittgen, W., Drings, P., Dienemann, H., Kayser, K.W., Schulz, V., Bartsch, H.: Rapid screening assay for mutagen sensitivity and DNA repair capacity in human peripheral blood lymphocytes. Mutagenesis, 16, 25-30 (2001)
29. Popanda, O., Ebbeler, R., Twardella, D., Helmbold, I., Gotzes, F., Schmezer, P., Thielmann, H.W., von Fournier D., Haase, W., Sautter-Bihl, M.L., Wenz, F., Bartsch, H., Chang-Claude, J.: Radiation-induced DNA damage and repair in lymphocytes from breast cancer patients and their correlation with acute skin reactions to radiotherapy. Int. J. Radiat. Oncol. Biol. Phys., 55, 1216-1225 (2003)
30. Wu, X., Zhao, H., Wie, Q., Amos, C.I., Zhang, K., Guo, Z., Qiao, Y., Hong, W.K., Spitz, M.R.: XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity. Carcinogenesis, 24, 505-509 (2003)
31. Udumudi, A., Jaiswal, M., Rajeswari, N., Desai, N., Jain, S., Balakrishna, N., Rao, K.V., Ahuja, Y.R.: Risk assessment in cervical dysplasia patients by single cell gel electrophoresis assay: a study of DNA damage and repair. Mutat. Res., 412, 195-205 (1998)
32. Blasiak, J., Arabski, M., Krupa, R., Wozniak, K., Rykala, J., Kolacinska, A., Morawiec, Z., Drzewoski, J., Zadrozny, M.: Basal, oxidative and alkylative DNA damage, DNA repair efficacy and mutagen sensitivity in breast cancer. Mutat. Res., 554, 139-148 (2004)
33. Bartkova, J., Horejsi, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J.M., Lukas, C., Ørntoft, T., Lukas, J., Bartek, J.: DNA damage response as a candidate anti-cancer barrier in early human tumourigenesis. Nature, 434, 864-870 (2005)
34. Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.V., Kolettas, E., Niforou, K., Zoumpourlis, V.C., Takaoka, M., Nakagawa, H., Tort, F., Fugger, K., Johansson, F., Sehested, M., Andersen, C.L., Dyrskjot, L., Ørntoft, T., Lukas, J., Kittas, C., Helleday, T., Halazonetis, T.D., Bartek, J., Gorgoulis, V.G.: Oncogene-induced senescence is part of the tumourigenesis barrier imposed by DNA damage checkpoints. Nature, 444, 633-637 (2006)
35. Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre, M., Nuciforo, P.G., Bensimon, A., Maestro, R., Pelicci, P.G., d'Adda di Fagagna, F.: Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature, 444, 638-642 (2006)
36. Kaneko, M., Arihiro, K., Takeshima, Y., Fujii, S., Inai, K.: Loss of heterozygosity and microsatellite instability in epithelial hyperplasia of the breast. J. Exp. Ther. Oncol., 2, 9-18 (2002)
37. Euhus, D.M., Cler, L., Shivapurkar, N., Milchgrub, S., Peters, G.N., Leitch, A.M., Heda, S., Gazdar, A.F.: Loss of heterozygosity in benign breast epithelium in relation to breast cancer risk. J. Natl. Cancer Inst., 94, 858-860 (2002)
38. DiTullio, R.A., Jr Mochan, T.A., Venere, M., Bartkova, J., Sehested, M., Bartek, J., Halazonetis, T.D.: 53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer. Nature Cell Biol., 4, 998-1002 (2002)